Whitener Capital Management’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $1.04M | Sell |
8,214
-219
| -3% | -$28.9K | 0.22% | 87 |
|
|
2026
Q1 | $1.18M | Sell |
8,433
-446
| -5% | -$62.5K | 0.27% | 71 |
|
|
2025
Q4 | $1.09M | Buy |
8,879
+167
| +2% | +$20.3K | 0.25% | 77 |
|
|
2025
Q3 | $967K | Buy |
8,712
+249
| +3% | +$28.3K | 0.23% | 79 |
|
|
2025
Q2 | $938K | Sell |
8,463
-54
| -0.6% | -$5.75K | 0.25% | 78 |
|
|
2025
Q1 | $954K | Sell |
8,517
-140
| -2% | -$14.4K | 0.27% | 73 |
|
|
2024
Q4 | $800K | Sell |
8,657
-120
| -1% | -$10.8K | 0.22% | 77 |
|
|
2024
Q3 | $736K | Sell |
8,777
-759
| -8% | -$57.9K | 0.21% | 83 |
|
|
2024
Q2 | $654K | Sell |
9,536
-145
| -1% | -$9.68K | 0.2% | 86 |
|
|
2024
Q1 | $709K | Sell |
9,681
-250
| -3% | -$19.2K | 0.23% | 80 |
|
|
2023
Q4 | $805K | Sell |
9,931
-148
| -1% | -$11.5K | 0.29% | 69 |
|
|
2023
Q3 | $755K | Buy |
10,079
+13
| +0.1% | +$1K | 0.3% | 68 |
|
|
2023
Q2 | $776K | Sell |
10,066
-40
| -0.4% | -$3.19K | 0.3% | 68 |
|
|
2023
Q1 | $838K | Sell |
10,106
-521
| -5% | -$43.2K | 0.35% | 63 |
|
|
2022
Q4 | $912K | Sell |
10,627
-730
| -6% | -$57.8K | 0.4% | 58 |
|
|
2022
Q3 | $700K | Sell |
11,357
-90
| -0.8% | -$5.67K | 0.33% | 66 |
|
|
2022
Q2 | $707K | Buy |
11,447
+130
| +1% | +$8.05K | 0.32% | 67 |
|
|
2022
Q1 | $672K | Buy |
11,317
+1,010
| +10% | +$64.6K | 0.25% | 82 |
|
|
2021
Q4 | $748K | Sell |
10,307
-4,703
| -31% | -$324K | 0.27% | 77 |
|
|
2021
Q3 | $874K | Buy |
15,010
+2,068
| +16% | +$145K | 0.4% | 63 |
|
|
2021
Q2 | $891K | Buy |
12,942
+132
| +1% | +$8.81K | 0.35% | 66 |
|
|
2021
Q1 | $827K | Sell |
12,810
-2,200
| -15% | -$142K | 0.36% | 67 |
|
|
2020
Q4 | $874K | Sell |
15,010
-3,756
| -20% | -$227K | 0.4% | 64 |
|
|
2020
Q3 | $1.19M | Sell |
18,766
-4,760
| -20% | -$330K | 0.57% | 47 |
|
|
2020
Q2 | $1.81M | Buy |
23,526
+20
| +0.1% | +$1.53K | 0.94% | 26 |
|
|
2020
Q1 | $1.76M | Buy |
23,506
+1,010
| +4% | +$69.8K | 1.14% | 21 |
|
|
2019
Q4 | $1.46M | Sell |
22,496
-545
| -2% | -$35.5K | 0.76% | 40 |
|
|
2019
Q3 | $1.46M | Buy |
23,041
+1,590
| +7% | +$104K | 0.8% | 32 |
|
|
2019
Q2 | $1.45M | Sell |
21,451
-660
| -3% | -$43.4K | 0.82% | 29 |
|
|
2019
Q1 | $1.44M | Buy |
22,111
+1,575
| +8% | +$105K | 0.94% | 25 |
|
|
2018
Q4 | $1.28M | Buy |
20,536
+1,150
| +6% | +$80.4K | 0.95% | 26 |
|
|
2018
Q3 | $1.5M | Buy |
19,386
+151
| +0.8% | +$11.4K | 0.98% | 21 |
|
|
2018
Q2 | $1.36M | Buy |
19,235
+430
| +2% | +$30.4K | 1.07% | 21 |
|
|
2018
Q1 | $1.42M | Buy |
18,805
+1,850
| +11% | +$147K | 1.08% | 20 |
|
|
2017
Q4 | $1.21M | Buy |
+16,955
| New | +$1.29M | 1.04% | 20 |
|
Other funds holding GILD
LMFP
CIM
ATO
CGH
Whitener Capital Management's GILD Position: Q2 2026 in Review
Whitener Capital Management reduced its Gilead Sciences (GILD) stake by 2.6% in Q2 2026, selling an estimated $28.9K and leaving 8,214 shares worth $1.04M. The position accounts for 0.22% of the portfolio, ranked #87.
Whitener Capital Management first reported a position in GILD in Q4 2017 and has held it in 35 quarters since. The position peaked at $1.81M in Q2 2020. 690 funds tracked by Wall St. Rank hold GILD as of Q2 2026.
- Whitener Capital Management held 8,214 shares of Gilead Sciences worth $1.04M as of Q2 2026.
- Whitener Capital Management sold 219 Gilead Sciences shares in Q2 2026, an estimated $28.9K.
- Gilead Sciences made up 0.22% of Whitener Capital Management's portfolio in Q2 2026, its #87 holding.
- Whitener Capital Management first reported a position in Gilead Sciences in Q4 2017 and has held it in 35 quarters since.
- Whitener Capital Management's Gilead Sciences position peaked at $1.81M in Q2 2020.
- 690 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.
Based on Whitener Capital Management's 13F filing for Q2 2026, filed 10 Jul 2026.